ARC Group Securities Acq I

This filing provides the complete contractual and structural framework for the SPAC. It confirms the $10.00 trust value per share, the 18-month deadline (21 months with sponsor extension), redemption rights for public shareholders, and sponsor economics. The document reveals a sponsor with nominal cost basis and substantial potential profit. The CEO (Ian Hanna) is also an affiliate of the underwriter (ARC Group Securities LLC), creating a FINRA Rule 5121 conflict of interest requiring a qualified independent underwriter. The filing does not disclose a merger target, as the entity is still searching.

What changed: Form 8-K current report and accompanying audited financial statements announcing the consummation of the initial public offering and private placement. Per the Company’s 8-K and audited financial statements, the IPO closed on August 5, 2026, selling 10,500,000 public units at $10.00 each for $105,000,000 in gross proceeds, alongside a concurrent private placement of 140,000 units to Sponsor FDB I for $1,400,000. The registrant reported that $106,400,000 was initially deposited into a trust account at Efficiency, INC.; following distributions of $545,453.36 for IPO expenses and $854,546.64 for working capital, $105,000,000 remains in trust. Management disclosed a 12-month combination window expiring August 5, 2027, with a provision for a single three-month extension through November 5, 2027 if a definitive agreement is executed within the first year; audited notes state the Company has no approved plan to extend beyond August 5, 2027 and lacks capital resources to fund operations thereafter. Sponsor economics detail 5,175,000 Class B founder shares (purchased originally for $25,000), $360,453 in unpaid sponsor promissory debt owed to the Company, and a $20,000 monthly administrative service fee arrangement. The underwriters’ 45-day over-allotment option for 1,575,000 units went unexercised, and $1,575,000 in deferred underwriting fees are contractually waived if a business combination fails to close. Why it matters: This filing locks in the definitive trust balance ($105,000,000 net, equating to $10.00 per redeemable Class A ordinary share before interest/taxes) and establishes the absolute expiration calendar for any redemption event or mandatory liquidation. The explicit going-concern warning and disclosed operational funding shortfall heighten liquidation probability if no target signing occurs by August 5, 2027, making the extension mechanism critically important to shareholders. Detailing sponsor debt, founder equity concentration, and administrative fee streams quantifies insider leverage and potential conflicts during the capital-formation gap. The waiver of deferred underwriting fees upon termination preserves trust liquidity for public shareholders but does not override the sponsor’s limited indemnification obligations for third-party vendor claims.

What changed: Form 8-K filed to report the consummation of ARC Group Securities Acquisition I's initial public offering (IPO) and the entry into related definitive agreements, including underwriting, warrant, rights, trust, registration rights, private placement and administrative services agreements, and the appointment of directors and officers. The SPAC consummated its IPO of 10,500,000 units at $10.00 per unit, generating $105,000,000 in gross proceeds. Simultaneously, it completed a private placement of 140,000 units to the sponsor at $10.00 per unit, generating $1,400,000. A total of $105,000,000 was deposited into a trust account. The company also adopted its amended and restated memorandum and articles of association and entered into standard SPAC agreements (underwriting, warrant, rights, trust, letter, registration rights, private placement purchase, indemnity, and administrative services agreements). The business combination deadline is 12 months from the closing of the IPO, with a potential one-time three-month extension to 15 months if a definitive agreement is executed within 12 months. Why it matters: This filing establishes the fundamental mechanics for SPAC investors: the trust value ($105,000,000), trust per share ($10.00), business combination deadline (12 months from the IPO closing, subject to extension), and the initial lock-up and voting agreements for the sponsor and insiders. Investors can now track the trust value and redemption mechanics against this baseline.

What changed: Priced IPO of 10,500,000 units at $10.00, with a 45-day over-allotment option for up to 1,575,000 more. Each unit is one Class A ordinary share, one redeemable warrant and one right to one-quarter of a Class A share at the combination. The whole warrant buys one Class A share at $11.50, is exercisable 30 days after the combination if a registration statement is effective, expires five years after it, and is redeemable at $0.01 if the shares close at or above $18.00 for 20 of 30 trading days. Trust: $105,000,000, or $120,750,000 with full over-allotment, at $10.00 per unit. Why it matters: The combination period is 12 months from closing with a single three-month extension available only if a definitive business-combination agreement has been executed within those 12 months. That is a filed, conditional extension rather than a sponsor deposit, and it is not derivable by arithmetic from the closing date alone. Deferred underwriting is 1.5% of gross proceeds payable in cash at the combination, but ARC Group Securities LLC and Clear Street LLC also receive 420,000 representative shares (483,000 with full over-allotment). Efficiency INC. is trustee.

What changed: A Form 8-A for registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Exchange Act, serving as the administrative instrument to list Units, Class A ordinary shares, Rights, and Warrants on The Nasdaq Stock Market LLC. Nothing altered regarding the redemption calendar, trust preservation, or extension mechanisms. The filing merely confirms the exchange listing of securities whose structural terms were previously detailed in the Registration Statement initially filed on November 6, 2025 (File No. 333-291302). Each Unit consists of one Class A ordinary share and one right entitling the holder to receive one-fourth (1/4) of one Class A ordinary share, alongside one warrant exercisable for one Class A ordinary share. Class A ordinary shares carry a par value of $0.0001 per share. Chief Executive Officer Ian Hanna executed the registration on August 3, 2026, from the principal executive offices at 398 Mill Ave, Suite 201B, Tempe, AZ 85281. No updates were provided regarding the SEARCHING status, the 2027-08-05 liquidation deadline, or any planned shareholder votes. Why it matters: For investors tracking SPAC timelines and capital maintenance, this filing confirms the final regulatory step for secondary market tradability without modifying underlying economic terms. The Cayman Islands exempted company relies entirely on the initial prospectus and charter documents incorporated by reference to govern trust account distribution rules, redemption thresholds, and warrant/right conversion mechanics. With Ian Hanna signing solely to complete Nasdaq clearance, the capital stack remains static, and no target combination, due diligence disclosure, or operational partnership has been advanced. Absent new 8-K reports detailing acquisition progress or extension waivers, the investor position remains exposed to the default dissolution date with no interim operational revenue, customer claims, or technology deployments documented in this submission.

What changed: Amendment No. 4 to Form S-1 Registration Statement under the Securities Act of 1933, filed as an exhibits-only submission to attach an independent registered public accounting firm's consent (Exhibit 23.1) and update the Part II exhibit index. The registrant explicitly states the accompanying prospectus remains unchanged from the June 29, 2026 filing and that this submission modifies only administrative components. Regarding SPAC mechanics, the filing details founder share restructuring: the registrant notes its sponsor initially purchased 7,392,857 Class B ordinary shares for an aggregate price of $25,000 on October 17, 2025, and subsequently surrendered 2,217,857 Class B shares for no consideration on May 6, 2026, leaving 5,175,000 founder shares outstanding, with up to 675,000 subject to forfeiture depending on the underwriter’s over-allotment exercise. The registrant calculates the sponsor’s deemed acquisition cost at approximately $0.00483 per share if the over-allotment is fully exercised, structuring founder equity to represent 30% of post-offering outstanding shares based on a maximum proposed offering of 12,075,000 units. The registrant reaffirms the sponsor’s contractual obligation to purchase 140,000 private units at $10.00 per unit for an aggregate $1,400,000 simultaneously with the IPO, emphasizing these instruments carry zero residual value unless an initial business combination is consummated. Standard trust safeguards are reiterated in the filing: the registrant discloses that officers and directors have expressly waived all rights, titles, interests, or claims in the trust account, limiting recourse solely to funds derived from their direct public share ownership. The filing introduces no amendments to the redemption calendar, per-share trust distribution mechanics, extension protocols, or target search status. Other substantive elements include a finalized schedule of estimated issuance expenses totaling $700,000 ($225,000 legal fees, $30,000 printing and engraving, $50,000 SEC/FINRA expenses, $80,000 Nasdaq listing fees, $100,000 underwriter legal fees, and $215,000 miscellaneous costs). The revised exhibit index formally incorporates a warrant agreement and a rights agreement both issued between 'Efficiency, INC.' and the registrant, alongside supporting contracts such as a promissory note dated October 16, 2025, subscription agreements dated October 16 and October 29, 2025, a founder shares forfeiture agreement dated May 6, 2026, audit and compensation committee charters, and signed nomination consents for Daniel A. Mace, Patrik Hriczo, and Jennifer Goforth. The registrant also files a formal consent from Marcum Asia CPAs LLP dated May 18, 2026, granting expert designation for financial statement coverage. Why it matters: Investors monitoring the SPAC trajectory should recognize this filing as routine pre-effectiveness housekeeping that preserves the existing structural timeline while cementing key capitalization mechanics ahead of public trading. By locking in the founder share surrender protocol and tying forfeiture triggers directly to the underwriter’s over-allotment exercise, the registrant clarifies future dilution exposure once units begin trading. The sponsor’s binding $1,400,000 private unit commitment establishes baseline confidence signaling, while the executives’ documented waivers of trust account claims reinforce that public capital remains insulated for redemption purposes only. Because the prospectus terms remain entirely static, the August 5, 2027 termination window and current redemption framework operate unchanged, shifting investor focus toward over-allotment market demand, target disclosure timing, and confirmation of Efficiency, INC.’s role in warrant and rights structures prior to final effectiveness.

What changed: A routine compliance exhibit filing — specifically, an exhibits-only Amendment No. 3 to Form S-1 Registration Statement under the Securities Act of 1933, submitted to add Exhibit 5.2 (a Cayman Islands legal opinion) and update the Part II exhibit index. Item 15 of the filing discloses that on October 17, 2025, the sponsor purchased 7,392,857 Class B ordinary shares for an aggregate price of $25,000, and on May 6, 2026, surrendered 2,217,857 of those shares for no consideration, leaving 5,175,000 founder shares outstanding, with up to 675,000 subject to forfeiture depending on the underwriter’s over-allotment exercise. The filing states the sponsor committed to purchasing 140,000 private units at $10.00 per unit for a total of $1,400,000 concurrently with the public offering. Item 13 lists estimated non-underwriting expenses totaling $700,000, comprised of $225,000 in legal fees, $30,000 in printing, $50,000 in SEC/FINRA expenses, $80,000 in Nasdaq listing fees, $100,000 in underwriter legal fees, and $215,000 in miscellaneous costs. Exhibit 5.2 provides a legal opinion confirming the Company’s authorized capital of 500,000,000 Class A ordinary shares, 50,000,000 Class B ordinary shares, and 5,000,000 preference shares, each with a US$0.0001 par value, and validates the due authorization of the proposed sale of up to 10,500,000 units (expanding to 12,075,000 units with full over-allotment) at US$10.00 per unit, where each unit comprises one Class A ordinary share, one warrant exercisable at $11.50 per share, and one right to receive one-fourth of a Class A ordinary share upon business combination. Why it matters: As an exhibits-only post-effective amendment, this filing does not alter the prospectus, meaning the trust account mechanics, shareholder redemption terms, and the 2027-08-05 deadline remain exactly as stated in the June 29, 2026 registration statement. The documented reduction of founder shares from approximately 7.4 million to 5,175,000, coupled with the explicit forfeiture triggers, highlights the sponsor’s pre-pricing alignment adjustments. The confirmed $1,400,000 private unit purchase secures parallel equity capital contingent on deal execution. Because the registrant remains in the searching phase with no target identified or business combination progress reported, the document’s substantive takeaway is the maintenance of standard SPAC structuring parameters and the regulatory stepping stone provided by the Cayman Islands counsel opinion ahead of pricing.

What changed: Amendment No. 2 to a Registration Statement on Form S-1 for the initial public offering of ARC Group Securities Acquisition I, a blank-check SPAC seeking to raise $105 million by selling 10.5 million units at $10.00 each. This S-1/A (Amendment No. 2) updates the IPO prospectus to, among other things: (i) reflect the surrender of 2,217,857 founder shares by the sponsor on May 6, 2026, reducing outstanding Class B shares to 5,175,000 (up to 675,000 subject to forfeiture depending on over-allotment exercise); (ii) disclose that on June 18, 2026, ARC Group Limited sold approximately 94% of its equity in the sponsor to Brynner Chiam, who became the manager with sole voting and investment discretion; (iii) specify a 12-month completion window with a single 3-month extension if a definitive agreement is executed within the first 12 months; (iv) change the per-unit warrant from one-half to one whole warrant and add a new right entitling the holder to receive one-quarter of one Class A share upon a business combination; (v) adjust the underwriting compensation to 420,000 representative shares plus a $1.575 million deferred underwriting fee; (vi) expand the anti-dilution conversion formula for founder shares to exclude redemptions related to charter amendments or the business combination; and (vii) update the dilution table to show net tangible book value per share after the offering ranging from $5.70 (at 0% redemption) to $(0.14) (at 100% redemption). Why it matters: These changes are material for investors tracking redemption mechanics, sponsor conduct, and valuation. The tightened 12-month completion window (from 18) increases redemption timing risk. The sponsor ownership change — particularly the transfer of control to Brynner Chiam — alters the sponsor incentive dynamic. The conversion formula adjustment shields sponsor shares from dilution caused by shareholder redemptions in charter amendments or the business combination, potentially increasing sponsor alignment risk. The addition of a full warrant (from one-half) per unit increases potential future dilution to 10.5 million shares at $11.50. The right to receive an additional 1/4 share upon business combination also increases potential dilution. The pre-offering net tangible book deficit of $(0.05) and post-offering deficit of $(0.14) (in a 100% redemption scenario) confirm the trust is at $10.00/unit but the sponsor's nominal $0.00483 per founder share cost creates severe dilution risk for public shareholders (101.8% dilution in a 100% redemption scenario).